CTLA4 and agammaglobulinemia: For instance, mutations in TNFRSF13B, NFKB1, NFKB2, CTLA4 and STAT3 are indications for the early molecular diagnosis of patients with predominantly antibody deficiency such as predominantly antibody deficiencies (19).